Michael B. Atkins, MD Deputy Director Professor, Oncology & Medicine Georgetown Lombardi Comprehensive Cancer Center discusses the efficacy of axitinib in combination with pembrolizumab in patients with advanced renal cell cancer.
Safety and efficacy of axitinib in combination with pembrolizumab in patients with advanced renal cell cancer
